Suppr超能文献

冷冻消融治疗肾癌:与其他治疗方式的比较及当前治疗综述

Cryoablation for the Treatment of Kidney Cancer: Comparison With Other Treatment Modalities and Review of Current Treatment.

作者信息

Bisbee Charles A, Zhang Jeremy, Owens Justin, Hussain Syed

机构信息

Radiology, HCA Florida Osceola Hospital, Kissimmee, USA.

Interventional Radiology, HCA Florida Osceola Hospital, Kissimmee, USA.

出版信息

Cureus. 2022 Nov 7;14(11):e31195. doi: 10.7759/cureus.31195. eCollection 2022 Nov.

Abstract

With cancer among the leading causes of death worldwide and kidney cancer among the more common cancers in the United States, it has become increasingly important to ensure that first-line treatments remain validated and supported in recent literature. Surgical intervention has long remained the gold standard for intervention but with newer techniques and technology on the horizon, there must be a constant review of other options that may provide improved outcomes and reduction of associated risks. Ablative techniques have gained traction and are becoming a valuable intervention for multiple different types of cancers, kidney cancer included. Cryoablation, a newer ablative technique taking advantage of extreme cold to freeze and destroy abnormal tissue, provides a promising option for treatment. Currently, no review article, to our knowledge, compares all the different treatment options for kidney cancer. Additionally, while some literature has addressed cryoablation in comparison to other methods of management, there has not been an extensive review to combine our current understanding of these comparisons. In this review article, we provide an overview of each of the commonly used treatments for kidney cancer and summarize the current literature regarding the advantages and disadvantages of each intervention. Finally, we seek to compare cryoablation, a newer option for treatment, to each of the approaches with the goal of evaluating the best methods for management and determining cryoablation's role alongside these current interventions.

摘要

癌症是全球主要死因之一,肾癌是美国较为常见的癌症之一,因此确保一线治疗在近期文献中仍得到验证和支持变得越来越重要。长期以来,手术干预一直是干预的金标准,但随着新技术和新科技的出现,必须不断审视其他可能改善治疗效果并降低相关风险的选择。消融技术越来越受到关注,正成为包括肾癌在内的多种不同类型癌症的一种有价值的干预手段。冷冻消融是一种利用极寒来冷冻和破坏异常组织的新型消融技术,为治疗提供了一个有前景的选择。据我们所知,目前尚无综述文章比较肾癌的所有不同治疗选择。此外,虽然一些文献已将冷冻消融与其他治疗方法进行了比较,但尚未有全面的综述来整合我们目前对这些比较的理解。在这篇综述文章中,我们概述了肾癌常用的各种治疗方法,并总结了关于每种干预措施优缺点的当前文献。最后,我们试图将冷冻消融这种新的治疗选择与每种方法进行比较,目的是评估最佳的治疗方法,并确定冷冻消融在这些现有干预措施中的作用。

相似文献

1
2
Percutaneous Cryoablation for Renal Cell Carcinoma.
J Kidney Cancer VHL. 2015 Jun 9;2(3):105-113. doi: 10.15586/jkcvhl.2015.34. eCollection 2015.
3
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Eur Urol. 2019 Aug;76(2):244-251. doi: 10.1016/j.eururo.2019.04.026. Epub 2019 May 3.
4
Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
BJU Int. 2012 Aug;110(4):510-6. doi: 10.1111/j.1464-410X.2011.10885.x. Epub 2012 Feb 3.
5
Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation.
Curr Opin Urol. 2008 Sep;18(5):467-73. doi: 10.1097/MOU.0b013e32830a735b.
7
Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
J Urol. 2008 Jul;180(1):104-9; discussion 109. doi: 10.1016/j.juro.2008.03.046. Epub 2008 May 15.
8
Modern Management of Localized Renal Cell Carcinoma- Is Ablation Part of the Equation?
J Kidney Cancer VHL. 2022 Aug 15;9(3):5-23. doi: 10.15586/jkcvhl.v9i3.233. eCollection 2022.
9
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6.
10
Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.
Semin Intervent Radiol. 2019 Dec;36(5):367-373. doi: 10.1055/s-0039-1696650. Epub 2019 Dec 2.

引用本文的文献

1
Transbronchial Cryoablation as Local Treatment for Central Airway Malignant Tumor.
Respiration. 2024;103(9):587-592. doi: 10.1159/000540299. Epub 2024 Jul 22.
3
Kidney Cancer and Potential Use of Urinary Extracellular Vesicles.
Oncol Rev. 2024 May 23;18:1410450. doi: 10.3389/or.2024.1410450. eCollection 2024.

本文引用的文献

1
The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.
Eur Urol. 2022 Dec;82(6):613-622. doi: 10.1016/j.eururo.2022.06.017. Epub 2022 Jul 14.
2
A Systematic Review and Meta-Analysis of Minimally Invasive Partial Nephrectomy Versus Focal Therapy for Small Renal Masses.
Front Oncol. 2022 May 26;12:732714. doi: 10.3389/fonc.2022.732714. eCollection 2022.
4
Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.
Theranostics. 2022 Feb 14;12(5):2175-2204. doi: 10.7150/thno.67530. eCollection 2022.
5
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391.
7
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
J Urol. 2021 Aug;206(2):199-208. doi: 10.1097/JU.0000000000001911. Epub 2021 Jul 11.
8
Cryoablation of renal tumors: long-term follow-up from a multicenter experience.
Abdom Radiol (NY). 2021 Sep;46(9):4476-4488. doi: 10.1007/s00261-021-03082-z. Epub 2021 Apr 29.
9
Individualizing Systemic Therapies in First Line Treatment and beyond for Advanced Renal Cell Carcinoma.
Cancers (Basel). 2020 Dec 13;12(12):3750. doi: 10.3390/cancers12123750.
10
Radiofrequency ablation: technological trends, challenges, and opportunities.
Europace. 2021 Apr 6;23(4):511-519. doi: 10.1093/europace/euaa328.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验